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Abstract
Objectives:Our goal was to investigate the correlation
between indocyanine green test results and imaging
parameters in living liver donor candidates.
Materials and Methods: Our study included 219 healthy
donor candidates who were evaluated with Doppler
ultrasonography (portal vein time average flow),
computed tomography (liver volume), liver biopsy (fat
fraction), and indocyanine green retention rate at 15
minutes.
Results: Portal vein time average flow (r= -0.375), fat-free
liver volume/body weight ratio (r = -0.239), and portal
vein time average flow × fat-free liver volume/body
weight ratio (r = -0.424) showed significant correlations
with indocyanine green retention rate at 15 minutes
(all P < .001).
Conclusions: Imaging parameters were significantly
correlated with indocyanine green retention rate at 15
minutes in living liver donor candidates.
Key words: Indocyanine green retention test, Liver
transplantation, Liver volume-to-body weight ratio
Introduction
Indocyanine green (ICG) is a water-soluble, fluo -
rescent tricarbocyanine dye that binds to plasma
protein and is distributed in the blood.1 Extraction
from the blood occurs exclusively by the liver, with
selective uptake across the sinusoidal plasma
membrane and removal via a carrier-mediated
mechanism2; ICG is excreted into the bile without
extrahepatic excretion or metabolism.3 The ICG test
is most commonly used for dynamic quantitative
assessment of liver function, especially in cases of
major liver resection, including living-donor liver
transplant.
A quantitative liver function test, including the
ICG test, relies on the clearance principle, in which
hepatic clearance is the product of liver blood flow
and liver extraction capacity.2 Doppler ultraso -
nography is routinely used to preoperatively assess
the vasculature in living-donor liver transplant and
has been proven to be a reliable technique for esti -
mating liver blood flow.4,5 Computed tomo graphy
(CT) is a standard technique to pre operatively evaluate
liver volume in potential living donors.6 Functional
liver volume reflects the liver extraction capacity in
healthy individuals with normal hepatic function.2 We
hypothesized that, among healthy living donors, the
ICG test could reflect portal vein (PV) flow as a
component of liver blood flow by Doppler
ultrasonography and functional liver volume by CT
volumetry that excludes nonmetabolic liver tissue such
as fat fraction.
The aim of our study was to investigate the
correlation between ICG test results and imaging
parameters, such as PV flow by Doppler ultraso -
nography and functional liver volume by CT
volumetry, excluding nonmetabolic liver tissue (eg,
fat fraction), in healthy donor candidates.
Materials and Methods
Study population
Our institutional review board approved this
retrospective study and waived the requirement for
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informed consent. We consecutively included a total
of 219 healthy donor candidates who were evaluated
by Doppler ultrasonography, CT scan, percutaneous
liver biopsy, and the ICG test between January 
2011 and July 2011 to determine their suitability to
serve as living liver donors. There were 136 
men (mean age [± standard deviation] of 28.6 ± 8.9 y;
range, 16-59 y) and 83 women (mean age of 33.3 ± 10.5
y; range, 16-58 y), with an overall mean age of 
30.4 ± 9.8 years (range, 16-59 y). The demographic
data of the living donor candidates are summarized
in Table 1.
Doppler ultrasonography techniques and analysis
Hepatic ultrasonographic examinations, including
Doppler studies, were performed by board-certified
abdominal radiologists using a Sequoia 512 machine
(Acuson Siemens, Mountain View, CA, USA)
equipped with a 1- to 4-MHz curved-array
transducer. The main PV diameter was measured at
the point from the porta hepatis to the right PV/left
PV bifurcation. Standard Doppler parameters 
were measured by adjusting velocity scale and 
angle correction. The time average velocity of 
the PV (PV TAV, cm/s) was obtained within the
center of the main PV where laminar flow is greatest,
setting its dimension as wide as ≥ 50% of the vessel
diameter, at the end of expiration with a spontaneous
short breath-hold. The time average flow (TAF,
cm3/min) of the PV was calculated using the
following equation: PV TAF = PV area (cm2) × PV
TAV (cm/s) × 60 (where PV area was determined by
π × [PV diameter/2]2). To minimize measurement
error, all parameters were measured 3 times and
were averaged for the analysis.
computed tomography scans and automated
computed tomography volumetry
Computed tomography scans were performed using
16-row multidetector CT scanners (Somatom
Sensation 16; Siemens Medical Solutions, Erlangen,
Germany). After unenhanced CT scans were
obtained, we administered 150 mL of iopromide
(Ultravist 370; Bayer Schering, Berlin, Germany) at a
flow rate of 3 mL/s using a mechanical injector
(Percupump II; E-Z-Em, Westbury, NY, USA).
Biphasic CT images were obtained during the
hepatic arterial phase (HAP) and portal venous
phase (PVP). By using bolus-tracking methods
(CARE-Bolus, Siemens Medical Solutions), HAP
scanning was initiated 10 seconds after the
enhancement of the descending aorta reached 100
HU; PVP scanning was initiated 40 seconds after
HAP scanning.
We used computer-aided hepatic volumetry on
PVP CT images. The initial hepatic outline was
detected through the sequential application of
seeded region growing onto level-set speed images,
which were generated as a map inversely
proportional to the gradient magnitude.7 The Malladi
level-set method8 was adopted for level-set
propagation. A rolling ball algorithm and the
removal of false-positive findings were then 
used to enhance the hepatic boundary more
accurately. The liver volume was calculated
automatically.
Histologic examination of hepatic steatosis and 
fat-free liver volume-to-body weight ratio
Donors underwent percutaneous ultrasonographically
guided biopsies of the right liver with an 18-gauge
needle (Stericut; TSK Laboratory, Tochigi, Japan) on
the same day as the CT examination. The degree of
hepatic steatosis replacing the hepatic parenchyma
was evaluated quantitatively using a percentage
scale.
To assess the functioning hepatic mass, excluding
the fat, relative to the body size, fat-free liver volume-
to-body weight ratio (FFLBWR) was calculated using
the following formula: FFLBWR = (estimated liver
volume on CT volumetry × [100 – percentage of
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table 1. Demographic Data and Summary of Results in the 219 Living Liver
Donor Candidates
Variable Result
Clinical characteristic
• Age, y 30.4 ± 9.8 (range, 16-59)
• Male, No. (%) 136 (62.1%)
• Female, No. (%) 83 (37.9%)
• Height, cm 168.8 ± 9.0 (142.6-190.5)
• Weight, kg 65.5 ± 11.7 (40.5-104.7)
Doppler US parameters
• PV diameter, mm 11.0 ± 0.2 (7.2-18.0)
• PV TAV, cm/s 22.5 ± 5.2 (11.5-40.0)
• PV TAF, cm3/min 1297.8 ± 476.0 (419.5-3357.3)
Estimated liver volume on CT 
volumetry, mL 1144.5 ± 252.4 (670.0-2294.0)
Hepatic steatosis degree on liver 
biopsy, % 7.3 ± 10.9 (0-50)
FFLBWR 1.6 ± 0.3 (0.9-2.3)
ICG R15, % 8.0 ± 3.1 (0.7-17.4)
Abbreviations: CT, computed tomography; FFLBWR, fat-free liver volume-
to-body weight ratio; ICG R15, indocyanine green retention rate at 15
minutes; PV, portal vein; TAF, time average flow; TAV, time average velocity;
US, ultrasonography
Unless otherwise indicated, results are means ± standard deviations, with
ranges in parentheses.
hepatic steatosis on histologic examination]/ -
100)/body weight.
ındocyanine green test
The ICG test was performed by rapid intravenous
injection of 0.5 mg/kg body weight of ICG (Dong-in
Dang Pharmaceutical Co., Siheong, Korea). Blood
samples were drawn from an antecubital vein
opposite to the site of injection, before and 15
minutes after ICG administration. After centri -
fugation, each sample was measured at 805 nm 
using a spectrophotometer (Hitachi, Kyoto, 
Japan). Indocyanine green test reten tion rate 
at 15 minutes (ICG R15) was expressed as a 
percentage of the fluorescent dye retained at 15
minutes.
Statistical analyses
Descriptive data are shown as means and standard
deviations. Spearman correlation coefficients 
were used to assess the relationships between 
ICG R15 and PV TAF, FFLBWR, and PV 
TAF × FFLBWR. Statistical analyses were 
performed using IBM SPSS Statistics for Windows,
version 21.0 (IBM Corp., Armonk, NY, USA). 
P values < .05 were considered to be statistically
significant.
Results
The means ± standard deviations and ranges of
imaging parameters, including PV diameter, 
PV TAV, PV TAF, estimated liver volume 
on CT volumetry, degree of hepatic steatosis, 
FFLBWR, and ICG 15 values, are summarized in 
Table 1.
relationship between portal vein time average flow
and indocyanine green test retention rate at 15
minutes
Our results showed that PV TAF was weakly
correlated with ICG R15 (r = -0.375, P < .001) (Table 2,
Figure 1).
relationship between fat-free liver volume/body
weight ratio and indocyanine green test retention rate
at 15 minutes
Our results showed that FFLBWR was weakly
correlated with ICG R15 (r = -0.239, P < .001) (Table 2,
Figure 2).
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Figure 1. Scatter Plots Demonstrating the Relationship Between Portal Vein
Time Average Flow and Indocyanine Green Retention Rate at 15 Minutes
Abbreviations: ICG R15, indocyanine green retention rate at 15 minutes; PV,
portal vein; TAF, time average flow
table 2. Correlations Between Indocyanine Green Test Results and Imaging
Parameters
PV TAF FFLBWR PV TAF × FFLBWR
ICG R15 r = -0.375, P < .001 r = -0.239, P < .001 r = -0.424, P < .001
Abbreviations: FFLBWR, fat-free liver volume-to-body weight ratio; ICG
R15, indocyanine green retention rate at 15 minutes; PV, portal vein; TAF,
time average flow
Figure 2. Scatter Plots Demonstrating the Relationship Between Fat-Free Liver
Volume-to-Body Weight Ratio and Indocyanine Green Retention Rate at 15
Minutes
Abbreviations: FFLBWR, fat-free liver volume-to-body weight ratio; ICG
R15, indocyanine green retention rate at 15 minutes
relationship between portal vein time average flow
× fat-free liver volume-to-body weight ratio and
indocyanine green test retention rate at 15 minutes
Our results showed that PV TAF × FFLBWR was
moderately correlated with ICG R15 (r = -0.424, 
P < .001) (Table 2, Figure 3).
Discussion
We evaluated the correlations between ICG R15 and
imaging parameters in living liver donor candidates
with well-preserved liver function. In our study, PV
TAF, FFLBWR, and PV TAF × FFLBWR were
significantly correlated with ICG R15.
On the basis of animal experimental studies,9,10 the
ICG test was initially introduced to estimate hepatic
blood flow. In a prior study of healthy human
subjects,11 the ICG test showed the possibility of being
used for estimating hepatic blood flow, compared 
with the previously established method utilizing
sulfobromophthalein. Although ICG-based hepatic
blood flow measurement has the disadvantage of
invasiveness, Doppler ultrasonography allows a
noninvasive study of hepatic circulation in real time.5
Moreover, in vitro studies have shown that hepatic
blood flow measurements by Doppler ultrasono -
graphy were accurate and reproducible,4,12 and an in
vivo study conducted in healthy human subjects
reported that Doppler ultrasonography was reliable
for estimation of portal blood flow.13 In a prior study
from Bolognesi and associates14 in patients with
compensated cirrhosis, an estimation of portal blood
flow by Doppler ultrasonography was correlated
with ICG-based hepatic blood flow. In our study with
a relatively large number of healthy subjects, PV TAF,
as surrogate of hepatic blood flow, was significantly
correlated with ICG R15, which is consistent with
this prior study,14 but the correlation was weak.
Another component of the ICG test is liver
extraction capacity; notably, functional liver volume
reflects liver extraction capacity. Prior studies have
reported that liver parenchymal cell volume,
measured by CT, and functional liver volume,
estimated by magnetic resonance imaging with
hepatobiliary-specific contrast agent, showed
significant correlations with ICG R15.15,16 In our
study, we proposed FFLBWR to access functional
liver volume in living donor candidates. It is well-
known that donor liver steatosis can reduce the
functional hepatic volume.6,17 Therefore, we used the
FFLBWR as a surrogate of functional liver volume;
we observed a significant correlation between
FFLBWR and ICG R15, although this correlation was
also weak.
The ICG retention test is a quantitative test that
represents both liver blood flow and functional
hepatic reserve. In our study, when we multiplied PV
TAF by FFLBWR, this parameter showed moderate
correlations with ICG R15 versus the weak
correlations shown for both PV TAF and FFLBWR.
Therefore, we suggest that PV TAF, as a surrogate of
total liver flow, multiplied by FFLBWR, reflecting
functional liver reserve in healthy subjects with well-
preserved liver function, improves the correlation
with ICG R15.
The ICG retention test is commonly used,
especially in the East. However, facilities to measure
ICG R15 are not readily available in all countries
worldwide. In addition, the ICG test requires
additional invasiveness and cost. In contrast,
ultrasonography and CT are routinely used for
preoperative evaluations to determine appropriateness
of candi dates as potential living donors. In this respect,
it may be valuable to acknowledge that hepatic blood 
flow, estimated by Doppler ultrasonography, and
functional liver volume, measured by CT volumetry
modified according to the degree of steatosis, can
reflect the ICG test. We suggest that the correlation
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Figure 3. Scatter Plots Demonstrating the Relationship Between Portal Vein
Time Average Flow Multiplied by Fat-Free Liver Volume/Body Weight Ratio
and Indocyanine Green Retention Rate at 15 Minutes
Abbreviations: FFLBWR, fat-free liver volume-to-body weight ratio; ICG
R15, indocyanine green retention rate at 15 minutes; PV, portal vein; TAF,
time average flow
between imaging parameters and ICG test results
may help clinicians decide appropriateness of a
candidate as a living liver donor, especially in some
centers where facilities to measure ICG R15 are not
available.
Our study has some limitations. First, we did not
include hepatic arterial flow by Doppler ultrasonog -
raphy in our measurements of liver blood flow. 
Total liver blood flow is calculated as the sum of
hepatic arterial flow and PV flow.5 However, clear
visualization of the hepatic artery and Doppler
measurements of hepatic arterial flow are possible
for only a limited population because of their deep
location, where ultrasonography signals are dis -
turbed to a large degree with scatters and clutters;
the small size, close to the spatial resolution of the
conventional convex transducer; and large vari -
abilities in anatomic configurations of the vessels.4,12
In contrast, portal blood flow estimation by Doppler
ultrasonography has been proven reliable and
reproducible in both healthy subjects and cirrhotic
patients.13,14 Therefore, we used portal blood flow as
a surrogate of liver blood flow. Second, we included
only healthy living liver donor candidates; therefore,
the results cannot be generalized to patients with liver
disease. Third, we did not consider the relationship
between the ICG test and static assessments of liver
function, including excretory function (total bilirubin)
and synthetic function (albumin and prothrombin
time). Indocyanine green and bilirubin bind to the
same carrier system in hepatocytes; thus, the ICG
transport capacity is competitively inhibited in cases
of hyperbilirubinemia.1,2 However, the patients
enrolled in this study were healthy subjects with
normal liver function. We suspect that the ICG test
solely relied on hepatic clearance, consisting of liver
blood flow and liver extraction capacity, in our study
population.
In conclusion, imaging parameters, including 
PV TAF, FFLBWR, and PV TAF × FFLBWR, were
significantly correlated with ICG R15 in healthy
subjects recruited from a pool of living liver donor
candidates.
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